InsidersTradesSigma
Track the Verademics, Inc. stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.3bn. The latest transaction was disclosed on 19 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Averill Madison Master Fund, Ltd.. Every trade is free.
Analysts rate Verademics, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$62.05.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Verademics, Inc. is a company listed on the XNAS market. It specializes in developing online assessment and training solutions.